Mother and child (MDMG) 股票預測
AI 預測: MDMG
AI 會發佈下一個交易日、週末及月底的目標價。變動幅度以最新價格為基準計算。這些均為統計估算，並非投資建議。
過去 6 個月價格
Premium 顯示此股票及其他所有股票嘅 AI 目標價：1 日、1 星期同 1 個月。
解鎖 Premium🔒 預測紀錄
預測紀錄 — 將過往預測與實際收市價對照 — 屬 Premium 功能。
解鎖 Premium關於呢間公司
Mater and Ditya is one of the leaders of the Russian private healthcare market. Founded in 2006 by obstetrician-gynecologist Mark Kurtser, the company now holds a leading position in Russia in the field of women’s and children’s health. The company’s assets include 11 high-tech hospitals, 44 clinics, and one medical university. The medical facilities specialize in a broad range of healthcare services, providing care in reproductive medicine, women’s health, and pediatrics, as well as in the treatment of socially significant diseases, including oncology and cardiology. In 2022, the company ranked second in Forbes’ “Top 20 Medical Companies – 2022” ranking, with revenue of RUB 25 billion.
